Tudogyogyintezet Torokbalint

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Lung cancer6 trials
• COPD1 trial

Phase

• Phase 36 trials
• Phase 41 trial

Status

• Completed4 trials
• Active, not recruiting3 trials

Lead sponsor

• Amgen1 trial
• AstraZeneca1 trial
• Daiichi Sankyo1 trial
• EMD Serono Research & Development Institute, Inc.1 trial
• Hoffmann-La Roche1 trial
• and 2 more

Running trials

• Active, not recruiting

  Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

  NCT05874401· Phase 4· Pharmacosmos A/S· Source

• Active, not recruiting

  Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

  NCT04656652· Phase 3· Daiichi Sankyo· Source

• Active, not recruiting

  A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients

  NCT03390686· Phase 3· Prestige Biopharma Limited· Source

Closed trials

• Completed

  Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

  NCT04303780· Phase 3· Amgen· Source

• Completed

  A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

  NCT04256421· Phase 3· Hoffmann-La Roche· Source

• Completed

  Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

  NCT04053634· Phase 3· AstraZeneca· Source

• Completed

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· Phase 3· EMD Serono Research & Development Institute, Inc.· Source